[RGLS] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 9.77%
YoY- 42.86%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 5,000 18 18 18 18 -
PBT -6,795 -7,133 -1,315 -4,893 -8,502 -14,506 -20,015 -16.47%
Tax 1 214 7 -131 61 -58 5 -23.51%
NP -6,796 -7,133 -1,322 -4,893 -8,563 -14,448 -20,020 -16.47%
Tax Rate - - - - - - - -
Total Cost 6,796 7,133 6,322 4,911 8,581 14,466 20,038 -16.48%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 -26.44 -27,183.33 -47,572.22 -80,266.67 -111,222.22 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.40 -0.67 -0.28 -2.34 -9.75 -16.68 -45.39 -54.53%
EPS Diluted -0.40 -0.67 -0.28 -2.34 -9.75 -16.68 -45.39 -54.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.